@wistlebower99.

SOME ADVICE FOR YOU:
1. Please don't give any conclusion about a company without knowing any basic knowledge of accounting or finance.

2. Some of the information or assumptions given was not true or misleading. Please do research for the true information.

2. Do you think that a company without any plans to do businesses is better than a
company which has a plan to do businesses?

What kind of THE BLIND PARROT company analyst you are. The cheap plug spammer. Haish

MY ACCUSATION ON YOU:
1. Infact, I suspect you have an ulterior motive.

2. Your analysis on certain companies looked bias, untrue and misleading. It's not fair to the company and its current share holders.

3. I'm afraid if you're one of the spammers who could gain much by spamming certain counter and speculating on the counter for your own sake.

I’m asking you a question. Are you holding any Fintec shares?????

@focusinvestor. Congratulation.

Nexgram secured RM36 million Saliva-based Test kits Sales Contract [12 Aug 2021] Press Release

Nexgram Holdings Berhad (Nexgram) wholly owned subsidiary Associate Partners Laboratories Sdn Bhd (APLab) secured RM36 million Covid-19 Antigen Nasal and Saliva Test kits procurement agreement with Covid-19 screening test kit distributor Ottigo Sdn Bhd (Ottigo).

Nexgram secured RM36 million Saliva-based Test kits Sales Contract [12 Aug 2021] Press Release

Nexgram Holdings Berhad (Nexgram) wholly owned subsidiary Associate Partners Laboratories Sdn Bhd (APLab) secured RM36 million Covid-19 Antigen Nasal and Saliva Test kits procurement agreement with Covid-19 screening test kit distributor Ottigo Sdn Bhd (Ottigo).

@wistlebower99.

SOME ADVICE FOR YOU:
1. Please don't give any conclusion about a company without knowing any basic knowledge of accounting or finance.

2. Some of the information or assumptions given was not true or misleading. Please do research for the true information.

2. Do you think that a company without any plans to do businesses is better than a
company which has a plan to do businesses?

What kind of THE BLIND PARROT company analyst you are. The cheap plug spammer. Haish

MY ACCUSATION ON YOU:
1. Infact, I suspect you have an ulterior motive.

2. Your analysis on certain companies looked bias, untrue and misleading. It's not fair to the company and its current share holders.

3. I'm afraid if you're one of the spammers who could gain much by spamming certain counter and speculating on the counter for your own sake.

I’m asking you a question. Are you holding any AT shares?????

@wistlebower99.

SOME ADVICE FOR YOU:
1. Please don't give any conclusion about a company without knowing any basic knowledge of accounting or finance.

2. Some of the information or assumptions given was not true or misleading. Please do research for the true information.

2. Do you think that a company without any plans to do businesses is better than a
company which has a plan to do businesses?

What kind of THE BLIND PARROT company analyst you are. The cheap plug spammer. Haish

MY ACCUSATION ON YOU:
1. Infact, I suspect you have an ULTERIOR MOTIVE.

2. Your analysis on certain companies looked bias, untrue and misleading. It's not fair to the company and its current share holders.

3. I'm afraid if you're one of the spammers who could gain much by spamming certain counter and speculating on the counter for your own sake.

I’m asking you a question. Are you holding any Nexgram shares?????

wistlebower99. ……..How many ICPS left to be converted? Only the holders know, we don't seem to have privilege to access the information.
--------------------
Without any completed research, wistlebower99 gives this conclusion/assumption. What a misleading statement been made by The Blind Parrot spammer.

Please refer here:

Remarks :

Pursuant to Section 74 of the Companies Act 2016, the issued share capital of RM99,062,381.59 of the Company is represented by 3,819,983,874 ordinary shares and 596,688,671 ICPS.

Source: https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3182487

@wistlebower99.

SOME ADVICE FOR YOU:
1. Please don't give any conclusion about a company without knowing any basic knowledge of accounting or finance.

2. Some of the information or assumptions given was not true or misleading. Please do research for the true information.

2. Do you think that a company without any plans to do businesses is better than a
company which has a plan to do businesses?

What kind of THE BLIND PARROT company analyst you are. The cheap plug spammer. Haish

MY ACCUSATION ON YOU:
1. Infact, I suspect you have an ulterior motive.

2. Your analysis on certain companies looked bias, untrue and misleading. It's not fair to the company and its current share holders.

3. I'm afraid if you're one of the spammers who could gain much by spamming certain counter and speculating on the counter for your own sake.

I’m asking you a question. Are you holding any Fast shares?????

@wistlebower99. Infact, I suspect you have an ulterior motive. Your analysis on certain companies looked bias, untrue and misleading.
It's not fair to the company and its current share holders.

I'm afraid if you're one of the spammers who could gain much by spamming certain counter and speculating on the counter for your own sake.

I ask you a question. Are you holding any Kanger shares????

@wistlebower99. Infact, I suspect you have an ulterior motive. Your analysis on certain companies looked bias, untrue and misleading.
It's not fair to the company and its current share holders.

I'm afraid if you're one of the spammers who could gain much by spamming certain counter and speculating on the counter for your own sake.

I ask you a question. Are you holding any Kanger shares?????

@OKU_2020 a.k.a MDP a.k. The Spammer Dog

Ambil dari segi positifnya. BOD sedang meningkatkan peratus pegangan sahamnya dalam syarikat. Setahu saya, ianya amat baik untuk syarikat.

BOD Hj Mazru sudah tingkatkan kepentingan sahamnya ke 10.855%. Memiliki saham sebanyak 414,400,000 unit. Tidak pernah jual setakat hari ini.

Sumber: https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3182520

@OKU_2020 a.k.a MDP a.k. The Spammer Dog

Ambil dari segi positifnya. BOD sedang meningkatkan peratus pegangan sahamnya dalam syarikat. Setahu saya, ianya amat baik untuk syarikat.

BOD Hj Mazru sudah tingkatkan kepentingan sahamnya ke 10.855%. Memiliki saham sebanyak 414,400,000 unit. Tidak pernah jual setakat hari ini.

Sumber: https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3182520

Besides supplying to government and corporate customers, Nexgram currently allow group purchase for Covid-19 Antigen Nasal and Saliva Self-Test kits, as well as Covid-19 Vaccine Efficacy Antibody Test Kits (doctors assigned) at Nexgram web portal https://nexgram.co/covidtestkit/

@OKU_2020 a.k.a MDP a.k. The Spammer Dog

Ambil dari segi positifnya. BOD sedang meningkatkan peratus pegangan sahamnya dalam syarikat. Setahu saya, ianya amat baik untuk syarikat.

BOD Hj Mazru sudah tingkatkan kepentingan sahamnya ke 10.855%. Memiliki saham sebanyak 414,400,000 unit. Tidak pernah jual setakat hari ini.

Sumber: https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3182520

How many ICPS left to be converted? Only the holders know, we don't seem to have privilege to access the information.
--------------------
Without any completed research, wistlebower99 gives this conclusion/assumption. What a misleading statement been made by The Blind Parrot spammer.

Please refer here:

Remarks :
Arising from the migration to no par value regime under the Companies Act 2016, par value is no longer relevant.

Pursuant to Section 74 of the Companies Act 2016, the issued share capital of RM99,062,381.59 of the Company is represented by 3,819,983,874 ordinary shares and 596,688,671 ICPS.

Source: https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3182487

@wistlebower99.

1. Please don't give any conclusion about a company without knowing any basic knowledge of accounting or finance.

2. Some of the information or assumptions given was not true or misleading. Please do research for the true information.

2. Do you think that a company without any plans to do businesses is better than a
company which has a plan to do businesses?

What kind of THE BLIND PARROT company analyst you are. The cheap plug spammer. Haish

@wistlebower99.

1. Please don't give any conclusion about a company without knowing any basic knowledge of accounting or finance.

2. Do you think that a company without any plans to do businesses is better than a
company which has a plan to do businesses?

What kind of THE BLIND PARROT company analyst you are. The cheap plug spammer. Haish

@wistlebower99.

Kita mungkin boleh perhatikan kebanyakan syarikat yang buat consolidation ialah apabila syarikat mengalami kerugian terkumpul yang banyak selain daripada NOSH yang besar. Banyak syarikat yang mempunyai masalah kerugian terkumpul yang besar akan buat capital reduction bersama-sama dengan proses consolidation.

Dan biasanya, syarikat yang mempunyai BOD yang hanya memiliki peratus saham yang sedikit biasanya suka buat consolidation. Ini kerana kesan negatif consolidation banyak ditanggung oleh pelabur runcit berbanding pemegang saham insider.

NOSH yang besar bukan jadi sebab mewajibkan sesebuah syarikat membuat consolidation. Kecualilah:

1. Keadaan kewangan syarikat amat memerlukan consolidation dibuat, contohnya dalam keadaan kerugian terkumpul yang banyak dalam kunci kira-kira.

2. Atau ada UDANG DISEBALIK BATU dalam kalangan pengurusan sesebuah syarikat tertentu.

JIKA NOSH besar, keadaan kewangan okay, harga saham pun OKAY, syarikat tersebut rasanya tak perlu buat consolidation. LIHAT SAJA CONTOH MY E.G. Bukannya nak buat consolidation tetapi menambahkan lagi jumlah NOSH syarikat sampai 8 bilion unit melalui Bonus Issue.

KAJIAN KES MELIBATKAN NEXGRAM:
1. Nexgram telah melaksanakan capital reduction dan ianya akan secara rasmi diambil kira ke dalam akaun bagi 4QR 2021. Semua kerugian terkumpul akan di offsett dengan perolehan capital reduction dan kunci kira-kira akan mula menunjukkan baki retained earning bermula dalam akaun 4QR 2021.
2. Berlaku perubahan struktur pemegangan saham dalam Nexgram. Pemegang saham dari kalangan BOD telah bertambah, contohnya Hj Mazru telah pegang kepentingan 10.588% dan ianya mungkin akan ditingkatkan sehingga 25% kepentingan saham.

Kesimpulan: Atas dasar tiada lagi masalah kerugian terkumpul yang besar dalam syarikat dan kepentingan saham yang dipegang dari kalangan insider syarikat adalah besar, maka saya rasa kemungkinan syarikat untuk membuat consolidation adalah lebih rendah.

https://klse.i3investor.com/blogs/mzm511/2021-08-05-story-h1568964980-Analysis_On_The_New_Development_Of_The_Kanger_s_Covid_19_Vaccine_Busine.jsp

@whistlebower99.

Kanger is still in progressing state in its current businesses, which are a bamboo flooring and related products, and Kanger also in its plan to venture in other business activities such as been involved in the construction services, in a process to acquire property for investment and in a final process to acquire a company which involved in a construction material trading.

All sort of the new investments in the new businesses has expanded via internally generated funds or by the issuance of new shares in Kanger. Its not involved any major debt financing facilities. Therefore the company can minimize the risks of higher debt burden by the company in the future. The financing facility via issuance of new shares also could minimize the cost of financing for the company.

If the new businesses are truly have good potential to improve the revenue and profitability of the company, I think the big NOSH issues should be no issues at all. He He

@whistlebower99.

Kanger's NOSH been uplifted in line for acquiring new projects or diversification. It was done for the development of the company businesses. The company is in their path to be more diversified and profitable.

----------------------------
On behalf of the Board, UOB Kay Hian wishes to announce that Bursa Securities had, vide its letter dated 30 June 2021, resolved to approve the listing and quotation of the following:-

i 713,157,273 new Kanger Shares to be issued pursuant to the Proposed Acquisition; and

ii. 769,513,179 new Kanger Shares to be issued pursuant to the Proposed Subscription

----------------------
and: Look at the good prospects from the proposed acquisition, for example:

https://www.theedgemarkets.com/article/kanger-confident-returning-black-fy22-driven-construction-business

New niche of business in Healthcare for Nexgram


Nexgram Covid-19 Vaccine Efficacy Antibody Testing Kit approved by MDA, inked group order from R Clinic

12 Aug 2021, Kuala Lumpur

Nexgram Holdings Bhd (Nexgram Group) wholly owned subsidiary Associate Partners Laboratories Sdn Bhd inked Covid-19 Vaccine Efficacy Antibody Test kits order from R Clinic.

The standing order procured through Tracvirus Clinic System is expected to service the government and private customers of Nexgram and R Clinic, as part of both companies corporate social responsibility program.

Besides supplying to government and corporate customers, Nexgram currently allow group purchase for Covid-19 Antigen Nasal and Saliva Self-Test kits, as well as Covid-19 Vaccine Efficacy Antibody Test Kits (doctors assigned) at Nexgram web portal https://nexgram.co/covidtestkit/

Priority is given to frontliners, essential industries, schools and construction sectors.

The SARS-CoV-2 Neutralising Test (a.k.a Surrogate Virus Neutralization Antibody Detection) can evaluate the Covid-19 vaccine efficacy. This is a highly specific test that detects antibodies, which block the interaction between Spike-RBD domain of the virus and the ACE2 receptor on the human cell. Blocking that interaction can prevent the virus from entering and infecting the cells.

Infection with SARS-CoV-2 initiates an immune response, which includes the production of antibodies, or binding antibodies, in the blood. Not all binding antibodies can block cellular infiltration and replication of the SARS-CoV-2 virus. The subpopulation of the binding antibodies that can block cellular infiltration and replication of the virus are named neutralizing antibodies. While individuals infected with SARS-CoV-2 develop binding antibodies to the virus, not all of them develop neutralizing antibodies to SARS-CoV-2.

Source: https://nexgram.co/2021/08/12/nexgram-tracvirus-covid-19-vaccine-efficacy-antibody-testing-kit-approved-by-mda/

@18KHarmoni. Mana ada NPRA lah kawan, dodol.....
NPRA sedang proses kelulusan vaksin lah. Vaksin wabak cheap plug spammer untuk 18KHarmoni.. He He He.

@18KHarmoni. Sabarlah. Kamu dah cucuk ke belum? Kalau belum memang betullah kalau kamu macam tak sabar je menunggu vaksin Sinopharm.

Ada ubi, ada batas,
Orang buli, kita balas... He He He

@whistlebower99. Do you think that a company without any plans to do businesses is better than a company which has a plan to do businesses?
What kind of THE BLIND PARROT company analyst you are. The cheap plug spammer. Haish

@whistlebower99. Do you think that a company without any plans to do businesses is better than a company which has a plan to do businesses?
What kind of THE BLIND PARROT company analyst you are. The cheap plug spammer. Haish

@whistlebower99. Do you think that a company without any plans to do businesses is better than a company which has a plan to do businesses?
What kind of THE BLIND PARROT company analyst you are. The cheap plug spammer. Haish

@whistlebower99. Do you think that a company without any plans to do businesses is better than a company which has a plan to do businesses?
What kind of THE BLIND PARROT company analyst you are. The cheap plug spammer. Haish

@whistlebower99. Do you think that a company without any plans to do businesses is better than a company which has a plan to do businesses?
What kind of THE BLIND PARROT company analyst you are. The cheap plug spammer. Haish

@whistlebower99. Do you think that a company without any plans to do businesses is better than a company which has a plan to do businesses?
What kind of THE BLIND PARROT company analyst you are. The cheap plug spammer. Haish

@whistlebower99. Do you think that a company without any plans to do businesses is better than a company which has a plan to do businesses?
What kind of THE BLIND PARROT company analyst you are. The cheap plug spammer. Haish

@whistlebower99. Do you think that a company without any plans to do businesses is better than a company which has a plan to do businesses?
What kind of THE BLIND PARROT company analyst you are. The cheap plug spammer. Haish
12/08/2021 10:23 PM

@whistlebower99.
Read this: https://klse.i3investor.com/blogs/mzm511/2021-06-14-story-h1566192317-The_Current_Status_of_MOU_and_Agreements_Relating_To_NEXGRAM_0096.jsp

@whistlebower99. Do you think that a company without any plans to do businesses is better than a company which has a plan to do businesses?
What kind of THE BLIND PARROT company analyst you are. The cheap plug spammer. Haish

@whistlebower99.

Kanger is still in progressing state in its current businesses, which are a bamboo flooring and related products, and Kanger also in its plan to venture in other business activities such as been involved in the construction services, in a process to acquire property for investment and in a final process to acquire a company which involved in a construction material trading.

All sort of the new investments in the new businesses has expanded via internally generated funds or by the issuance of new shares in Kanger. Its not involved any major debt financing facilities. Therefore the company can minimize the risks of higher debt burden by the company in the future. The financing facility via issuance of new shares also could minimize the cost of financing for the company.

If the new businesses are truly have good potential to improve the revenue and profitability of the company, I think the big NOSH issues should be no issues at all. He He

https://malaysia.yahoo.com/news/eu-looks-pfizer-moderna-vaccine-071054530.html

Friends.

1. You better find more information about this issue. Better get true information based on what happened recently to the company after the company triggered with MUGC (GN3/PN17 listed issuer) but has been given relief.

Officially, currently Nexgram is not in the list of GN3 listed issuer company because it has given the relief by BURSA. The issues related to the MUGC which was triggered on Nexgram can be
read at: https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3099172


2. Based on the 3Q 2021 report, Nexgram's shareholder equity on consolidated basis of its shares excluding treasury shares

= (RM121,482,625 ÷ 215,119,923) x 100%

= 56.47 %

Conclusion:

3QR on 2QR, shareholder's equity of its shares increased from 51.23% in the last 2QR 2021 report to 56.47%.
@@Remarks: GN3 risk ?? Lowered

Source: https://klse.i3investor.com/blogs/mzm511/2021-07-01-story-h1567122502-SOME_ANALYSIS_FROM_THE_3QR_2021_OF_NEXGRAM_0096.jsp


3. Nexgram won’t be listed as GN3 issuers because:

a. The capital reduction has been approved and be executed. Its can help to clear off the accumulated losses in the companys account, and the company will record the small accumulated profit in the company’s account.

b. Nexgram's shareholders equity on consolidated basis of its shares (excluding treasury shares)
in 3QR 2021 was getting better, already at 56.27%.

c. There is no more new MUGC triggered in FY 2020 up to today because its shareholders equity on consolidated basis of its shares (excluding treasury shares) has surpassed the 50% figure.


@wistlebower99. I invested in this company started from few years ago. I agree with you about the past records of the company which always in red started from FY 2016 up to FY 2020. Before that the company's FY was profitable.

We simply can refer here to confirm it:
https://klse.i3investor.com/servlets/stk/fin/0096.jsp

But started from 2QR 2021 of FY 2021, there are some improvement has been reported in term of revenue and profitability of the company. Also it shareholder equity on consolidated basis of its shares excluding treasury shares has been improved @ above 50%. A great achievement for the company in turning around its FA conditions. All these improvement almost because of its new busineses related to healthcare / medical.

Please refer to my articles:

1. https://klse.i3investor.com/blogs/mzm511/2021-07-01-story-h1567122502-SOME_ANALYSIS_FROM_THE_3QR_2021_OF_NEXGRAM_0096.jsp

2. https://klse.i3investor.com/blogs/MZM2511/2021-05-11-story-h1565005629-The_Competitive_Edge_of_NEXGRAM_0096_in_Vaccine_Passports_and_Digital_F.jsp

3. https://klse.i3investor.com/blogs/mzm511/2021-06-14-story-h1566192317-The_Current_Status_of_MOU_and_Agreements_Relating_To_NEXGRAM_0096.jsp

@OKU_2020 a.k.a MDP a.k. The Spammer Dog

Ambil dari segi positifnya. BOD sedang meningkatkan peratus pegangan sahamnya dalam syarikat. Setahu saya, ianya amat baik untuk syarikat.

BOD Hj Mazru sudah tingkatkan kepentingan sahamnya ke 10.855%. Memiliki saham sebanyak 414,400,000 unit. Tidak pernah jual setakat hari ini.

New niche of businesses in Healthcare for Nexgram

Nexgram Covid-19 Vaccine Efficacy Antibody Testing Kit approved by MDA, inked group order from R Clinic
12 Aug 2021, Kuala Lumpur

Nexgram Holdings Bhd (Nexgram Group) wholly owned subsidiary Associate Partners Laboratories Sdn Bhd inked Covid-19 Vaccine Efficacy Antibody Test kits order from R Clinic.

The standing order procured through Tracvirus Clinic System is expected to service the government and private customers of Nexgram and R Clinic, as part of both companies corporate social responsibility program.

Besides supplying to government and corporate customers, Nexgram currently allow group purchase for Covid-19 Antigen Nasal and Saliva Self-Test kits, as well as Covid-19 Vaccine Efficacy Antibody Test Kits (doctors assigned) at Nexgram web portal https://nexgram.co/covidtestkit/

Priority is given to frontliners, essential industries, schools and construction sectors.

The SARS-CoV-2 Neutralising Test (a.k.a Surrogate Virus Neutralization Antibody Detection) can evaluate the Covid-19 vaccine efficacy. This is a highly specific test that detects antibodies, which block the interaction between Spike-RBD domain of the virus and the ACE2 receptor on the human cell. Blocking that interaction can prevent the virus from entering and infecting the cells.

Infection with SARS-CoV-2 initiates an immune response, which includes the production of antibodies, or binding antibodies, in the blood. Not all binding antibodies can block cellular infiltration and replication of the SARS-CoV-2 virus. The subpopulation of the binding antibodies that can block cellular infiltration and replication of the virus are named neutralizing antibodies. While individuals infected with SARS-CoV-2 develop binding antibodies to the virus, not all of them develop neutralizing antibodies to SARS-CoV-2.

Source: https://nexgram.co/2021/08/12/nexgram-tracvirus-covid-19-vaccine-efficacy-antibody-testing-kit-approved-by-mda/

@OKU_2020 a.k.a The Spammer Dog dengan multi ID sedang buat kacau...
Memang dari dulu kamu BUAT KERJA JAHAT macam ni?

@ Sudah disahkan OKU_2020 dan pemburuscammer dan 3 ID lainnya di dalam forum ini menggunakan IP address yang sama.

OKU_2020 a.k.a The Spammer Dog meroyan bila PERANGAI JAHAT DAH TERBONGKAR..

WOWWWW MUNGKINKAH ADA TAMBAHAN LAGI KLON ID BAHARU???/

---- KEJAHATAN kamu sudah terdedah....

---- KETIDAK SIUMAN sekaranglah padah...

PERCAYA DENGAN ORANG YANG PENUH BERMUKA-MUKA ?? KASIHAN...

@whistlebower99. It's been given to a director which is BOD Tn Hj Mazru, and two other ICPS receipients are Ozura and Capital Day (2which are not the BOD but the trade creditors). Three of them were the creditors of Nexgram at that time.

The company at that time have difficulty to pay for the debt owed from the creditors because the company in financial stress (in FY 2019), therefore the company settled the amount owing to them by offering them a big amount off ICPS.

The big quantity of ICPS offered to them was influenced by the low price of Nexgram shares at that time. For your information the price of Nexgram's share was around 0.5 sen - 1.0 sen (End of 2018 - July 2020).

You can refer to: CIRCULAR TO SHAREHOLDERS IN RELATION TO THE (I) PROPOSED SETTLEMENT OF DEBT OWING TO A DIRECTOR AND SELECTED CREDITORS OF NEXGRAM IN THE AGGREGATE SUM OF RM23,454,664.65 TO BE FULLY SATISFIED THROUGH THE ISSUANCE OF 2,345,466,465 IRREDEEMABLE CONVERTIBLE PREFERENCE SHARES AT AN ISSUE PRICE OF RM0.01 EACH; AND (II) PROPOSED AMENDMENTS TO THE CONSTITUTION OF NEXGRAM

Source: https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3000426

@whistlebower99.

Kanger is still in progressing state in its current businesses, which are a bamboo flooring and related products, and Kanger also in its plan to venture in other business activities such as been involved in the construction services, in a process to acquire property for investment and in a final process to acquire a company which involved in a construction material trading.

All sort of the new investments in the new businesses has expanded via internally generated funds or by the issuance of new shares in Kanger. Its not involved any major debt financing facilities. Therefore the company can minimize the risks of higher debt burden by the company in the future. The financing facility via issuance of new shares also could minimize the cost of financing for the company.

If the new businesses are truly have good potential to improve the revenue and profitability of the company, I think the big NOSH issues should be no issues at all. He He

@whistlebower99.

Kanger's NOSH been uplifted in line for acquiring new projects or diversification. It was done for the development of the company businesses. The company is in their path to be more diversified and profitable.

----------------------------
On behalf of the Board, UOB Kay Hian wishes to announce that Bursa Securities had, vide its letter dated 30 June 2021, resolved to approve the listing and quotation of the following:-

i 713,157,273 new Kanger Shares to be issued pursuant to the Proposed Acquisition; and

ii. 769,513,179 new Kanger Shares to be issued pursuant to the Proposed Subscription

----------------------
and: Look at the good prospects from the proposed acquisition, for example:

https://www.theedgemarkets.com/article/kanger-confident-returning-black-fy22-driven-construction-business

whistlebower99 Good luck MZM.
--------------
You're welcome.

It's true. I stuck in this company for years already. I am sticking to hold the shares as I still have a piece of hopes on the company. By the way, I 'm NOT blindly made that decision without any effort to do some research on the company's development into the positive condition.

Anyway, TAYOR and thanks again for your ADVICE.

@whistlebower99

Boleh diperhatikan kebanyakan syarikat yang buat consolidation ialah apabila syarikat mengalami kerugian terkumpul yang banyak selain daripada NOSH yang besar. Banyak syarikat yang mempunyai masalah kerugian terkumpul yang besar akan buat capital reduction bersama-sama dengan proses consolidation.

Dan biasanya, syarikat yang mempunyai BOD yang hanya memiliki peratus saham yang sedikit biasanya suka buat consolidation. Ini kerana kesan negatif consolidation banyak ditanggung oleh pelabur runcit berbanding pemegang saham insider.

NOSH yang besar bukan jadi sebab mewajibkan sesebuah syarikat membuat consolidation. Kecualilah:

1. Keadaan kewangan syarikat amat memerlukan consolidation dibuat, contohnya dalam keadaan kerugian terkumpul yang banyak dalam kunci kira-kira.

2. Atau ada UDANG DISEBALIK BATU dalam kalangan pengurusan sesebuah syarikat tertentu.

JIKA NOSH besar, keadaan kewangan okay, harga saham pun OKAY, syarikat tersebut rasanya tak perlu buat consolidation. LIHAT SAJA CONTOH MY E.G. Bukannya nak buat consolidation tetapi menambahkan lagi jumlah NOSH syarikat sampai 8 bilion unit melalui Bonus Issue.

KAJIAN KES MELIBATKAN NEXGRAM:
1. Nexgram telah melaksanakan capital reduction dan ianya akan secara rasmi diambil kira ke dalam akaun bagi 4QR 2021. Semua kerugian terkumpul akan di offsett dengan perolehan capital reduction dan kunci kira-kira akan mula menunjukkan baki retained earning bermula dalam akaun 4QR 2021.
2. Berlaku perubahan struktur pemegangan saham dalam Nexgram. Pemegang saham dari kalangan BOD telah bertambah, contohnya Hj Mazru telah pegang kepentingan 7% dan ianya mungkin akan ditingkatkan sehingga 25% kepentingan saham.

whistlebower99 Have a feeling that the directors should be planning to call for shares consolidation followed by rights issue to squeeze more money out of shareholders within this year.

Substantial shareholders starting to dispose off their shares.

TAYOR
--------------
Frankly, I would like to suggest you to do some research on who is the substantial shareholders you referred to. Please don't give any conclusion about a company without knowing the true story of the issues. You will be A BLIND PARROT. Sorry.

Highly unlikely Muhyiddin will call for early Parliament meeting, say analysts

https://www.themalaysianinsight.com/s/332719

@whistlebower99

Boleh diperhatikan kebanyakan syarikat yang buat consolidation ialah apabila syarikat mengalami kerugian terkumpul yang banyak selain daripada NOSH yang besar. Banyak syarikat yang mempunyai masalah kerugian terkumpul yang besar akan buat capital reduction bersama-sama dengan proses consolidation.

Dan biasanya, syarikat yang mempunyai BOD yang hanya memiliki peratus saham yang sedikit biasanya suka buat consolidation. Ini kerana kesan negatif consolidation banyak ditanggung oleh pelabur runcit berbanding pemegang saham insider.

NOSH yang besar bukan jadi sebab mewajibkan sesebuah syarikat membuat consolidation. Kecualilah:

1. Keadaan kewangan syarikat amat memerlukan consolidation dibuat, contohnya dalam keadaan kerugian terkumpul yang banyak dalam kunci kira-kira.

2. Atau ada UDANG DISEBALIK BATU dalam kalangan pengurusan sesebuah syarikat tertentu.

JIKA NOSH besar, keadaan kewangan okay, harga saham pun OKAY, syarikat tersebut rasanya tak perlu buat consolidation. LIHAT SAJA CONTOH MY E.G. Bukannya nak buat consolidation tetapi menambahkan lagi jumlah NOSH syarikat sampai 8 bilion unit melalui Bonus Issue.

KAJIAN KES MELIBATKAN NEXGRAM:
1. Nexgram telah melaksanakan capital reduction dan ianya akan secara rasmi diambil kira ke dalam akaun bagi 4QR 2021. Semua kerugian terkumpul akan di offsett dengan perolehan capital reduction dan kunci kira-kira akan mula menunjukkan baki retained earning bermula dalam akaun 4QR 2021.
2. Berlaku perubahan struktur pemegangan saham dalam Nexgram. Pemegang saham dari kalangan BOD telah bertambah, contohnya Hj Mazru telah pegang kepentingan 7% dan ianya mungkin akan ditingkatkan sehingga 25% kepentingan saham.

@OKU_2020 a.k.a The Spammer Dog dengan multi ID memang cari makan di sini.
Dia macam Spammer Dog yang ada tuannya. Hi Hi.

Wallahu A'lam.

Wah... OKU_2020 a.k.a The Spammer Dog dengan multi ID sedang buat kacau.

Sudah disahkan OKU_2020 dan pemburuscammer dan 3 ID lainnya di dalam forum ini menggunakan IP address yang sama.

KEJAHATAN kamu sudah terdedah.... Siapa yang BERPELUH tentulah ORANG YANG SALAH..

KETIDAK SIUMAN sekaranglah padah...

PERCAYA DENGAN ORANG YANG BERMUKA EMPAT?? Kesian